Ignite Creation Date:
2024-05-06 @ 7:15 AM
Last Modification Date:
2024-10-26 @ 11:46 AM
Study NCT ID:
NCT02501434
Status:
SUSPENDED
Last Update Posted:
2022-03-04
First Post:
2015-07-13
Brief Title:
Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin
Sponsor:
Robert F James
Organization:
Indiana University
Study Overview
Official Title:
A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients With Significant Hemorrhage Burden
Status:
SUSPENDED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ASTROH
Brief Summary:
A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients with Significant Hemorrhage Burden - STUDY IS TEMPORARILY SUSPENDED WITH PLAN TO RESUME SOON NO SAFETY CONCERNS
Detailed Description:
The primary objective of this study is to investigate the safety and clinical effect of a continuous low-dose intravenous unfractionated heparin LDIVH infusion for the prevention of aneurysmal subarachnoid hemorrhage aSAH induced neurocognitive dysfunction and other delayed neurological deficits
Additionally increased blood and CSF levels of certain inflammatory biomarkers IL-6 hsCRP etc have been correlated to aSAH patients with poor clinical outcomes Unfractionated heparin UFH has known anti-inflammatory actions As a result a secondary objective of this study will be to evaluate whether LDIVH can reduce blood and CSF inflammatory biomarkers levels compared to controls and whether there is any association between inflammatory biomarker levels and cognitive outcomes in aSAH
Additionally increased blood and CSF levels of certain inflammatory biomarkers IL-6 hsCRP etc have been correlated to aSAH patients with poor clinical outcomes Unfractionated heparin UFH has known anti-inflammatory actions As a result a secondary objective of this study will be to evaluate whether LDIVH can reduce blood and CSF inflammatory biomarkers levels compared to controls and whether there is any association between inflammatory biomarker levels and cognitive outcomes in aSAH
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None